ARX:ASX
Aroa Biosurgery Ltd
AU$0.49
arrow_upward
+1.03%(+0.0050) 1D
ኖቬም 5, 4:10:29 ከሰዓት ጂ ኤም ቲ+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ARX...
Open
AU$0.52
High
AU$0.52
Low
AU$0.49
Mkt. cap
167.76 ሚ
Avg. vol.
282.16 ሺ
Volume
64.69 ሺ
P/E ratio
47.43
52-wk high
AU$0.80
52-wk low
AU$0.48
EPS
AU$0.01
Shares outstanding
345.90 ሚ
No. of employees
261
Open
AU$0.52
High
AU$0.52
Low
AU$0.49
Mkt. cap
167.76 ሚ
Avg. vol.
282.16 ሺ
Volume
64.69 ሺ
P/E ratio
47.43
52-wk high
AU$0.80
52-wk low
AU$0.48
EPS
AU$0.01
Shares outstanding
345.90 ሚ
No. of employees
261
News stories
From web sources and news partners
www.marketscreener.com
·
ከ2 ቀናት በፊት
Aroa Biosurgery : Mark Dunwoodie appointed as Chief Financial Officer
Profile
Aroa Biosurgery Limited is a regenerative medicine company that develops, manufactures and distributes products for wound healing and soft tissue reconstruction. Aroa Biosurgery is headquartered in Auckland, New Zealand with a US office in San Diego, CA, and is listed on the Australian Securities Exchange.
The company, originally known as Mesynthes Limited, was founded in 2008 by Veterinarian Surgeon Dr Brian Ward. The company develops and commercializes products based on its proprietary ovine forestomach matrix technology platform with products in wound healing as well as plastics and reconstructive surgery and repair of hernia. Wikipedia
About Aroa Biosurgery Ltd